Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma - a podcast by American Society of Clinical Oncology (ASCO)

from 2013-12-16T17:49:05

:: ::

This podcast provides observations and commentary on the study by Payne and colleagues entitled ‘Phase II Pilot Study of Intravenous High Dose Interferon with or without Maintenance Treatment in Melanoma at High Risk of Recurrence.'

Further episodes of Journal of Clinical Oncology (JCO) Podcast

Further podcasts by American Society of Clinical Oncology (ASCO)

Website of American Society of Clinical Oncology (ASCO)